SUMO: from bench to bedside
HM Chang, ETH Yeh - Physiological Reviews, 2020 - journals.physiology.org
Sentrin/small ubiquitin-like modifier (SUMO) is protein modification pathway that regulates
multiple biological processes, including cell division, DNA replication/repair, signal …
multiple biological processes, including cell division, DNA replication/repair, signal …
Advancing epilepsy genetics in the genomic era
CT Myers, HC Mefford - Genome medicine, 2015 - Springer
Epilepsy is a group of disorders characterized by recurrent seizures, and is one of the most
common neurological conditions. The genetic basis of epilepsy is clear from epidemiological …
common neurological conditions. The genetic basis of epilepsy is clear from epidemiological …
Incidence and phenotypes of childhood-onset genetic epilepsies: a prospective population-based national cohort
JD Symonds, SM Zuberi, K Stewart, A McLellan… - Brain, 2019 - academic.oup.com
Epilepsy is common in early childhood. In this age group it is associated with high rates of
therapy-resistance, and with cognitive, motor, and behavioural comorbidity. A large number …
therapy-resistance, and with cognitive, motor, and behavioural comorbidity. A large number …
KCNQ2 encephalopathy: Emerging phenotype of a neonatal epileptic encephalopathy
Objective: KCNQ2 and KCNQ3 mutations are known to be responsible for benign familial
neonatal seizures (BFNS). A few reports on patients with a KCNQ2 mutation with a more …
neonatal seizures (BFNS). A few reports on patients with a KCNQ2 mutation with a more …
Improving diagnosis and broadening the phenotypes in early-onset seizure and severe developmental delay disorders through gene panel analysis
N Trump, A McTague, H Brittain… - Journal of medical …, 2016 - jmg.bmj.com
Background We sought to investigate the diagnostic yield and mutation spectrum in
previously reported genes for early-onset epilepsy and disorders of severe developmental …
previously reported genes for early-onset epilepsy and disorders of severe developmental …
Clinical whole-genome sequencing in severe early-onset epilepsy reveals new genes and improves molecular diagnosis
HC Martin, GE Kim, AT Pagnamenta… - Human molecular …, 2014 - academic.oup.com
In severe early-onset epilepsy, precise clinical and molecular genetic diagnosis is complex,
as many metabolic and electro-physiological processes have been implicated in disease …
as many metabolic and electro-physiological processes have been implicated in disease …
A common ankyrin-G-based mechanism retains KCNQ and NaV channels at electrically active domains of the axon
Z Pan, T Kao, Z Horvath, J Lemos, JY Sul… - Journal of …, 2006 - Soc Neuroscience
KCNQ (KV7) potassium channels underlie subthreshold M-currents that stabilize the
neuronal resting potential and prevent repetitive firing of action potentials. Here, antibodies …
neuronal resting potential and prevent repetitive firing of action potentials. Here, antibodies …
Dominant‐negative effects of KCNQ2 mutations are associated with epileptic encephalopathy
G Orhan, M Bock, D Schepers, EI Ilina… - Annals of …, 2014 - Wiley Online Library
Objective Mutations in KCNQ2 and KCNQ3, encoding the voltage‐gated potassium
channels KV7. 2 and KV7. 3, are known to cause benign familial neonatal seizures mainly …
channels KV7. 2 and KV7. 3, are known to cause benign familial neonatal seizures mainly …
Clinical spectrum of early onset epileptic encephalopathies caused by KCNQ2 mutation
Purpose KCNQ2 mutations have been found in patients with benign familial neonatal
seizures, myokymia, or early onset epileptic encephalopathy (EOEE). In this study, we aimed …
seizures, myokymia, or early onset epileptic encephalopathy (EOEE). In this study, we aimed …
Arrhythmia in heart and brain: KCNQ1 mutations link epilepsy and sudden unexplained death
AM Goldman, E Glasscock, J Yoo, TT Chen… - Science translational …, 2009 - science.org
Sudden unexplained death is a catastrophic complication of human idiopathic epilepsy,
causing up to 18% of patient deaths. A molecular mechanism and an identified therapy have …
causing up to 18% of patient deaths. A molecular mechanism and an identified therapy have …